EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Therapeutic Outcomes in Patients With Trichophyton indotineae : A Systematic Review and Meta‐Analysis of Individual Patient Data

Charussri Leeyaphan iD, Phuwakorn Saengthong-Aram, Jomgriditip Laomoleethorn, Phichayut Phinyo, Lalita Lumkul, Sumanas Bunyaratavej iD

Mycoses · 2025-04 · 68 (4)

DOI: 10.1111/myc.70048 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Mycoses, online erschienen am 05.04.2025. Verfasst von Charussri Leeyaphan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Antifungal Agents, Tinea, Trichophyton. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Trichophyton indotineae has emerged as a significant global dermatophyte, associated with recalcitrant dermatophytosis and increasing antifungal resistance. Materials and Methods This study evaluates therapeutic outcomes in T. indotineae infections. We conducted a systematic review and meta‐analysis of individual patient data adhering to PRISMA guidelines, including studies published before December 2023 from six electronic databases. Only studies with confirmed T. indotineae by rDNA sequencing and therapeutic outcome data were included.

Results

A total of 27 publications with 81 cases were included. T. indotineae infections affected both genders equally, with 25% having prior steroid use, which was significantly associated with non‐improvement. Resistance to terbinafine was observed in 85.3% of cases. Oral itraconazole was significantly associated with a cure. The restricted median time to complete clinical cure was 11.50 weeks, with a recurrence rate of 19.7%.

Conclusions

The effective management of T. indotineae infections is essential, given the significant challenges posed by antifungal resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsTineaTrichophytonHumansTreatment OutcomeTerbinafineDrug Resistance, FungalMaleItraconazoleFemaleAdultMiddle Aged

Stichwörter der Autor:innen

Trichophyton indotineaedermatophytesdermatophytosisfungal infection

Substanzen

Antifungal AgentsTerbinafineItraconazole

Autor:innen und Institutionen

  • Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Center for Clinical Epidemiology and Clinical Statistics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Department of Biomedical Informatics and Clinical Epidemiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Center of Multidisciplinary Technology for Advanced Medicine (CMUTEAM), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

ORCID-Profile: Charussri Leeyaphan, Sumanas Bunyaratavej

Zitieren

APA

Leeyaphan, C., Saengthong-Aram, P., Laomoleethorn, J., Phinyo, P., Lumkul, L., & Bunyaratavej, S. (2025). Therapeutic Outcomes in Patients With Trichophyton indotineae : A Systematic Review and Meta‐Analysis of Individual Patient Data. Mycoses, 68(4). https://doi.org/10.1111/myc.70048

Vancouver

Leeyaphan C, Saengthong-Aram P, Laomoleethorn J, Phinyo P, Lumkul L, Bunyaratavej S. Therapeutic Outcomes in Patients With Trichophyton indotineae : A Systematic Review and Meta‐Analysis of Individual Patient Data. Mycoses. 2025;68(4). doi:10.1111/myc.70048

BibTeX
@article{Leeyaphan2025,
  author = {Leeyaphan, Charussri and Saengthong-Aram, Phuwakorn and Laomoleethorn, Jomgriditip and Phinyo, Phichayut and Lumkul, Lalita and Bunyaratavej, Sumanas},
  title = {Therapeutic Outcomes in Patients With Trichophyton indotineae : A Systematic Review and Meta‐Analysis of Individual Patient Data},
  journal = {Mycoses},
  year = {2025},
  volume = {68},
  number = {4},
  doi = {10.1111/myc.70048}
}
Kostenlos starten →